Pharma Radar

One page per molecule: FDA applications and decisions, Orange Book patents and exclusivities, EMA authorisations and designations, registered trials — linked, dated, sourced, free.

Status
Private build. First test cohort: September 2026.
Coverage
20 molecules (US + EU). Public sources only: openFDA Drugs@FDA, FDA Orange Book data files, CDER expedited-programme lists, EMA medicines data, ClinicalTrials.gov.
Method
Deterministic extraction from machine-readable sources. No AI-generated content. Every fact links to its source record.
Not here
Therapeutic-equivalence judgements, patent-blocking conclusions, pricing, clinical advice.

Operated by Studio Legale Scarlino, Lecce (Italy) · studiolegalescarlino.com